Aclaris Therapeutics, Inc. (ACRS) Net income 2016–2025
Aclaris Therapeutics, Inc. (ACRS) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$64.9MFY2025 · since FY2016: -$48.1M → -$64.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$64.9M | +50.8% |
| FY2024 | -$132.1M | -49.3% |
| FY2023 | -$88.5M | -1.8% |
| FY2022 | -$86.9M | +4.4% |
| FY2021 | -$90.9M | -78.1% |
| FY2020 | -$51.0M | +68.4% |
| FY2019 | -$161.4M | -21.6% |
| FY2018 | -$132.7M | -93.7% |
| FY2017 | -$68.5M | -42.5% |
| FY2016 | -$48.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice